Clinical Trial Update: POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy [NA]

View source ↗

Summary

The clinical trial evaluating Valvosoft non-invasive ultrasound therapy for moderate aortic valve stenosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• VALVOSOFT

Snippet

Sponsor: Cardiawave SA | Conditions: Moderate Aortic Valve Stenosis | NA | Status: WITHDRAWN